Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Overview
Illness
Mental Illness
Addiction
Anxiety Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder (BPD)
Overview
Depression
Eating Disorders
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Other Brain-Related Illnesses
Overview
Category
Basic Research
New Technologies
Early Intervention/ Diagnostic Tools
Next Generation Therapies
Blog
Get Involved
Overview
Give
Donate Today
Memorial/Tribute (make donation)
Create Event or Memorial Page
Find a Memorial/Tribute Page
Planned Giving
Stock/Securities Donations / IRA Charitable Rollovers
Overview
Other Giving Opportunities
Research Partners
Workplace Giving
Team Up for Research!
Sponsorship Opportunities
Overview
Watch
Healthy Minds TV
Meet the Scientists Webinars
Videos
Overview
Connect
Ask the Expert
Join Us
Sign Up
Home
Grants
Overview
Grant FAQs
Overview
NARSAD Young Investigator Grants
Overview
NARSAD Independent Investigator Grants
Overview
NARSAD Distinguished Investigator Grants
Prizes & Awards
Overview
Klerman & Freedman Prizes
Overview
Outstanding Achievement Prizes
Lieber Prize for Schizophrenia Research
Maltz Prize for Schizophrenia Research
Colvin Prize for Mood Disorders Research
Ruane Prize for Child and Adolescent Psychiatric Research
Goldman-Rakic Prize for Cognitive Neuroscience Research
Overview
The Pardes Humanitarian Prize
Overview
Productive Lives Awards
Blog
About Us
Overview
Who We Are
Overview
Our Impact
Overview
FAQs
Media Center
Overview
News
Press Releases
Opinion Pieces
In the News
Overview
Publications
Overview
Multimedia Library
Overview
Media Kit
Events & Webinars
Overview
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup
Open Menu

Menu

opioids

opioids

Study Points to a New Class of Antidepressants
Study Points to a New Class of Antidepressants

Compounds that target a certain opioid receptor in the brain could be used to develop a new group of antidepressants, researchers reported in a study published in the journal Neuropsychopharmacology in September.

Read More

TOPICS

Tags

Immune System
maternal health
Memory Loss
Fear
Genetics
25 Years of Breakthroughs
Alcohol Addiction
Mental Illness (General)
Epigenetics
Drug Addiction
Fragile X Syndrome
antidepressants
neurotransmitters
Plasticity/Neuroplasticity
Developmental Disorders
exercise & mental health
Biomarkers
Stress
ketamine
side effects
Trauma
SSRI
Psychosis
CBT
Gender Differences
suicide
Copy-Number Variations
antipsychotics
cognitive deficits
Children & Adolescents
Intellectual Disability
DBS
Brain Stimulation
Alzheimer's Disease
Geriatric Mental Health
Anorexia Nervosa
lithium
ECT
anhedonia
Prevention
neuroticism
Bulimia
schizoaffective
1997
panic disorder
Spain
Metabolic Syndrome
Neurodegenerative Disorders
Cognition
Addiction
Infection & Mental illness
Metabolism
video
serotonin
White Matter/Grey Matter
sleep
Parkinson's Disease
Dietary Supplements
Folic Acid
pregnancy
Blog
Dopamine
Tourette syndrome
tic disorder
NARSAD Artworks
borderline personality disorder
Diet
Neurofeedback
Cognitive Impairment
Substance Abuse
hippocampus
Postpartum Depression
Talk Therapy
Transcranial Magnetic Stimulation (TMS)
Brain Imaging
DTI
Basal Ganglia
Lateral Habenula
Rett Syndrome
rapid-acting antidepressants
bipolar depression
suicide prevention
suicidal thinking
brain waves
electrical stimulation
disruptive mood dysregulation disorder
Mood Disorders
mental-illness multiple
prefrontal cortex
epilepsy
inhibitory neurons
synapses
Amygdala
Resilience
imaging
memory
Baclofen
mania
excitation/inhibition balance
neural networks
Microbiome
light therapy
Marijuana
Autism
behavioral therapy
cognitive behavioral therapy
brain mapping
cell biology
neurons
mu receptor
opioids
Fear Memory
early life trauma
Aging
longitudinal studies
major depressive disorder
recovery
electroconvulsive therapy
treatment-resistant depression
vagus nerve stimulation
VNS
fast-acting antidepressants
veterans
Metabolic Disorders
brain circuits
Cocaine
reward system
Neuroimaging
birth complications
Psychotherapy
suicide risk
Cannabis
THC
Cognitive Dysfunction
Myelination
Negative Symptoms
Motivation